A new pyranoflavone, methoxycyclocommunol (1) together with four known flavonoids, artonin F (2), heteroflavanone A (3), cudraflavone C (4) and cyclocommunol (5) were isolated from the bark of Artocarpus integer var. silvestris Corner. Their structures were elucidated through extensive spectroscopic techniques (UV, IR, MS, 1D-NMR and 2D-NMR) and by comparison with literature data. All the pure compounds were tested for their anti-inflammatory activities by using screening kit and radioimmunoassay methods. In a 15-lipoxygenase (15-LOX) inhibitory assay, compounds 1, 2, 4 and 5 gave weak percentages of inhibition, 16.5, 18.3, 17.6, 10.2%, respectively at the concentration of 100 µM. Compounds 1, 3 and 4, however, showed strong dosedependent inhibition towards prostaglandin E 2 (PGE 2 ) production in lipopolysaccharide-induced human whole blood using a radioimmunoassay method with IC 50 values of 4.3, 0.8, and 0.07 µM, respectively suggesting that they strongly exhibited cyclooxygenase-2 (COX-2) activity.
Since this species has been traditionally used for malarial remedies, several studies were performed to identify the active marker for treatment of this disease. An antimalarial-guided study led to the isolation of three prenylated stilbenes [3] . A study on A. integer collected from Indonesia revealed the isolation of one active marker, morachalcone A, for the treatment of malaria [4] . However, A. integer var. silvestris has not been studied, neither for its phytochemicals nor for their bioactivities. Therefore, we wish to report for the first time on the isolation of the phytochemicals and their anti-inflammatory properties. This research has led to the isolation of one new pyranoflavone, methoxycyclocommunol (1), along with four known flavonoids, artonin F (2), heteroflavanone A (3), cudraflavone C (4) and cyclocommunol (5) .
Fractionation of the dichloromethane (CH 2 Cl 2 ) extract of A. integer var. silvestris by vacuum liquid chromatography (VLC) gave seven major fractions (AIBD1-AIBD7). Purification of AIBD5 using repeated silica gel column chromatography followed by Sephadex LH-20 afforded a new pyranoflavone, methoxycommunol (1) , as yellow semi-solid (5.8 mg, 0.006%).
The HREIMS spectrum presented the molecular ion peak at m/z 366.1194 consistent with the molecular formula C 21 H 18 O 6. These data were supported by 13 C NMR analysis which revealed resonances for the presence of 21 carbons consisting of one methoxy, two methyls and seven methines and eleven quaternary carbons. The IR spectrum of 1 showed absorption bands for hydroxy (3325 cm -1 ) and chelated carbonyl (1601 cm -1) functionalities.
The structure elucidation of compound 1 was assisted by a comparison of the NMR spectroscopic data of cyclocommunol (5) [5] . The difference between the NMR spectroscopic data of 1 and 5 could be explained by the presence of sharp and intense peak associated with a methoxy group at δ 3.94. The 1 H NMR spectrum also exhibited signals at δ 6.33 (1H, d, J = 2.4 Hz) and δ 6.68 (1H, d, J = 2.4 Hz) for two meta-coupled aromatic protons which were assigned to H-8 and H-6, respectively. A downfield singlet at δ 12.87 was attributable to the chelated hydroxy group attached to C-5. This supported the assignment of the benzoyl moiety of compound 1.
The two intense sharp resonances observed at δ 1.70 and δ 1.96 indicated the presence of two methyl groups belong to the C-2 isobutentyl substituent of the pyrano ring. Two sets of doublet resonances with J = 9.2 Hz in the downfield region at δ 6.21 and δ 5.48 and were assigned to H-9 and H-10, respectively. The other significant signals at δ 6.45 (J = 2.4 Hz), 6 and HMBC experiments ( Figure 1 ). The COSY spectrum displayed a cross peak between H-5′ and H-6′ and between H-9 and H-10. The HMBC ( Figure 1 and Table 1 ) showed a correlation between the methoxy group and C-7 which confirmed the structure of 1 as a derivative of cyclocommunol with a methoxy substituent at C-7. The long range correlation between H-12 with C-11, C-12 and C-13 assisted the arrangement of the pyrano substituents which was attached between rings B and C.
The UV maximum absorptions of compound 1 in MeOH at 265 and 365 nm suggested the presence of a flavone skeleton [6] . The UV analysis showed no shift in band II upon addition of NaOAc indicated the absence of a 7-OH. The bathochromic shift observed for band I in the UV spectrum after addition of NaOAc, indicated the presence of a OH group at C-4. Thus UV analysis clarified the position of all the hydroxyl groups in 1.
On the basis of the above spectral evidence, compound (1) was established as structure 1 which to the best of our knowledge has never been reported. Compounds 2-5 were identified as artonin F (2) heteroflavanone A (3), cudraflavone C (4), and cyclocommunol (5) which were in agreement with literature data [5, [7] [8] [9] [10] .
All the pure compounds were tested for their anti-inflammatory properties on 15-lipoxygenase (15-LOX), however only compounds 1-4 were evaluated for COX-2 inhibition due to insufficient amount of compound 5. The anti-inflammatory screening by the 15-LOX assay using the Cayman screening kit for compounds 1, 2, 4 and 5 indicated weak inhibition with the percentage of inhibition of 18.3, 16.5, 17.6 and 10.2%, respectively at the concentration of 100 µM, while compound 3 was devoid of activity.
Compounds 1-4 were screened for inhibitory effects on production of PGE 2 in whole blood at a concentration of 10 µg/mL. Compounds with percentage inhibition more that 55% were successively evaluated by serial dilution concentrations in order to determine their IC 50 values. Cudraflavone C (4) exhibited the highest inhibition of vasoactive PGE 2 followed by heteroflavanone A (3), methoxycyclocommunol (1) and artonin F (2) with percentage of inhibition 79.4±0.42, 70.9±4.74, 66.6±2.86 and 52.9±2.80%, respectively relative to the positive control, indomethacin 84.6% ±1.50 ( Figure 2 ). Compound 4 showed the strongest inhibitory effect on COX-2 with an IC 50 value of 0.07 µM which was higher than indomethacin (IC 50 = 0.2 µM). This might be due to the high antioxidant property or ability to bind with the COX-2 active site and consequently gave direct inhibition of COX-2 activity [12] . As a PGE 2 inhibitor, compound 4 is also expected to be a positive inhibitor for phospholipase A2 (PLA 2 ) production [13] . Suppression of PGE 2 production; after treatment of the known non-selective inhibitor indomethacin, showed an inhibition of 84.6%. This was lower than dexamethasone, that could inhibit up to 90%. Dexamethasone is the strongest COX-2 inhibitor whereas indomethacin was equipotent inhibitor for COX-1 and COX-2 isoforms [14] . Compounds 1 and 3 also showed their ability to inhibit COX-2 with IC 50 values 4.3 and 0.8 µM, respectively (Table 2 ). However, our results showed conflicts with the previous reports for nitric oxide (NO) inhibitory activity for compound 3 and 4 [15] [16] . Although NO production was highly correlated with production of PGE 2 , the interaction between COXs and the NO pathway remain unclear [17] . This result shows the comparison in antiinflammatory properties towards two different enzymes.
All four compounds showed remarkable activity for COX-2 inhibition on PGE 2 production in human blood using a radioimmunoassay technique. Both 15-LOX and COX-2 inhibition assays do not show correlations for all the tested compounds. This means that they acted as a selective inhibitor in COX-2 pathway but not in 15-LOX pathway. Lipoxygenase and cyclooxygenase pathways produce different products, leukotrienes and prostanoids, respectively [11] . Compounds 1, 3 and 4 could be potential COX-2 selective inhibitors and potential chemopreventive agents [18] . 
Extraction and isolation:
The air-dried bark of A. integer var. silvestris (1.3 kg) was macerated with different polarity of solvents successively thrice (7.5 L each) at room temperature for 72 h. The filtrates were evaporated under reduced pressure to produce petroleum ether, CH 2 Cl 2 , EtOAc and MeOH crude extracts. The petroleum ether extract (25.44 g, 2.0%) was fractionated by increasing polarity of n-hexane and EtOAc using vacuum liquid chromatography to give seven major fractions (AIBP1-AIBP7).
Purification of AIBP3 was done using silica gel column chromatography (CC, n-hexane: EtOAc) and Sephadex LH-20 (MeOH) to give compound 2 (14.7 mg, 0.06%) and compound 3 (11.9 mg, 0.05%) as brown and white powders, respectively. Compound 1 (5.8 mg, 0.006%) was isolated from the CH 2 Cl 2 extract as a yellow semi-solid by repeated silica gel CC and Sephadex LH-20. Purification of the EtOAc extract by repeated silica gel CC and Sephadex LH-20 afforded compounds 4 (7.2 mg, 0.02%) and 5 (33.0 mg, 0.08%) as yellow solids.
Lipoxygenase Inhibitory Activity using Cayman Screening Kit:
LOX assay was carried out using a screening kit purchased from iDNA. Buffer, substrate, developing reagent and enzyme were included in the kit. Preparation of the reagents was carried out as instructed by the screening kit manual. The calculation of the percentage of inhibition was calculated using equation (1), whereas IA is the absorbance of the initial activity well.
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Radioimmunoassay for Prostaglandin E 2 (PGE 2 ):
The radioimmunoassay procedure was performed according to Juriyati et al. [13] . The application of human blood was permitted by the Ethics Committee of Universiti Kebangsaan Malaysia (UKM) with the approval number NF-016-2013. The assay required the venous blood from healthy human volunteers who fulfilled all the criteria such as non-smoker, fasted at least 8 h (allowed to drink water), not in menstruation period, age between 18-50 years old, had not taken any medications (NSAID or COXIBs) and alcohol within the last two weeks.
The blood needs to be stored immediately in polypropylene tubes containing 10% (v/v) of 2% EDTA upon withdrawal. Instantly, the tube was gently rotated to avoid blood coagulation or lysis. The procedure for the first day needs to be carried out within a maximum 2 h in order to preserve the blood. One mL of blood was transferred to each microtube containing 10 µL of sample/indomethacin dissolved in DMSO and ethanol (1:1 ratio). The negative control is DMSO and ethanol (1:1 ratio). Then, all the tubes were incubated for 15 min. at 37 °C (5% CO 2 ) before been incubated for 24 h after addition of 10 µL LPS (1 µg/mL in normal saline).
Next, the blood was centrifuged at 2600 g for 15 min at 4°C. The plasma (100 µL) was mixed with anti-PGE 2 (100 µL) and [ 3 H]-PGE 2 (100 µL) before incubated at 4 °C for 18-24 h. The next day, dextran-charcoal (100 µL) was added, centrifuged at 3000 g for 15 min at 4 °C and incubated for 10 min. Then, the supernatant (300 µL) was added to a liquid scintillation cocktail. The radioactivity was measured using a liquid scintillation analyser.
The inhibition of PGE 2 production was measured with the concentration of PGE 2 in human blood. The PGE 2 concentration was calculated using semi-logarithmic graph of the standard PGE 2 which was measured in serial dilution at concentrations 2.45 to 400 pg/0.1 mL. The net count of all the standards and samples were calculated using equation 2 where N c is non-specific binding, B o is total binding between antibody and antigen. The percentage inhibition was calculated using equation 3. 
